Dongju Shin

Dongju Shin

Auto-generated profile, based on publicly available information

Dongju Shin

Department of Chemistry, Yonsei University, Seoul, Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
DSDongju Shin
Dongju Shin
WLWookjae Lee
Wookjae Lee
JLJi Hyun Lee
Ji Hyun Lee
DBDuhee Bang
Duhee Bang
The authors developed a method for analyzing single cells under various conditions by tagging cells with small fragments of DNA.

30 June 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
DSDongju Shin
Dongju Shin
WLWookjae Lee
Wookjae Lee
JLJi Hyun Lee
Ji Hyun Lee
DBDuhee Bang
Duhee Bang
To simultaneously analyze multiple samples of various conditions with scRNA-seq, we developed a universal sample barcoding method through transient transfection of SBOs. A 48-plex drug treatment experiment of pooled samples analyzed by a single run of Drop-Seq revealed a unique transcriptome response for each drug and target-specific gene expression signatures at the single-cell level. Our cost-effective method is widely applicable for single-cell profiling of multiple experimental conditions.

19 November 2025 in Scientific Reports
Verified
Journal Article
Open access
DSDongju Shin
Dongju Shin
TKTaehoon Kim
Taehoon Kim
JLJaywon Lee
Jaywon Lee
HKHwang-Phill Kim
Hwang-Phill Kim
TKTae-You Kim
Tae-You Kim
DBDuhee Bang
Duhee Bang
Aberrant DNA methylation drives cancer development, yet current screening methods require substantial resources for targeted enrichment across multiple CpG-rich regions. Early cancer detection in cell-free DNA (cfDNA) presents additional challenges due to low circulating tumor DNA fractions (0.01–10%) that dilute cancer-specific signals. To address these limitations, we developed Restriction Enzyme-based CpG-methylated fragment AmPlification sequencing (RECAP-seq) to selectively enrich hypermethylated fragments from existing Enzymatic Methyl-seq (EM-seq) libraries. RECAP-seq combines EM-seq library preparation with BstUI restriction enzyme digestion to target CGCG motifs, achieving preferential enrichment of CpG islands. With spike-in experiments using cell line mixtures, RECAP-seq successfully distinguished samples as low as 0.001%. The method identified 7,091 hypermethylated markers, including ALX4 which showed progressive increases with colorectal cancer stage. Clinical validation using cfDNA from 35 healthy donors and 47 colorectal cancer patients demonstrated robust detection with an area under the curve (AUC) of 0.932, achieving 78.7% sensitivity at 95% specificity.

12 August 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
DSDongju Shin
Dongju Shin
JCJungwon Choi
Jungwon Choi
JLJi Hyun Lee
Ji Hyun Lee
DBDuhee Bang
Duhee Bang
The development of single-cell RNA-seq has broadened the spectrum for biological research by providing a high-resolution analysis of cellular heterogeneity. However, the requirement for sophisticated devices for the compartmentalization of cells has limited its widespread applicability. Here, we develop Onepot-Seq, a device-free method, that harnesses the transient localization of mRNA after lysis to capture single-cell transcriptomes simultaneously in a continuous fluid medium. In mixed-species experiments, we obtained high-quality single-cell profiles. Further, cell type-specific poly(A)-conjugated antibodies allow Onepot-Seq to effectively capture target cells in complex populations. Chemical perturbations to cells can be profiled by Onepot-Seq at single-cell resolution. Onepot-Seq should allow routine transcriptional profiling at single-cell resolution, accelerating clinical and scientific discoveries in many fields of science.